IL289586A - pi4kiii alpha micromolecule inhibiting preparation, method for its preparation and use - Google Patents
pi4kiii alpha micromolecule inhibiting preparation, method for its preparation and useInfo
- Publication number
- IL289586A IL289586A IL289586A IL28958622A IL289586A IL 289586 A IL289586 A IL 289586A IL 289586 A IL289586 A IL 289586A IL 28958622 A IL28958622 A IL 28958622A IL 289586 A IL289586 A IL 289586A
- Authority
- IL
- Israel
- Prior art keywords
- micromolecule
- preparation
- method therefor
- inhibitor composition
- inhibitor
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/285—Arsenic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Nutrition Science (AREA)
- Hospice & Palliative Care (AREA)
- Inorganic Chemistry (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2019094831 | 2019-07-05 | ||
| PCT/CN2020/100377 WO2021004422A1 (zh) | 2019-07-05 | 2020-07-06 | 小分子PI4KIIIα抑制剂组合物、其制备方法及用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL289586A true IL289586A (en) | 2022-03-01 |
Family
ID=74115038
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL289586A IL289586A (en) | 2019-07-05 | 2022-01-03 | pi4kiii alpha micromolecule inhibiting preparation, method for its preparation and use |
Country Status (15)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114685566A (zh) * | 2020-12-31 | 2022-07-01 | 江苏挪贝肽医药科技有限公司 | 氧化苯砷晶型i、晶型ii和晶型iii及其制备方法 |
| MX2024004055A (es) * | 2021-09-30 | 2024-06-19 | Nuo Beta Pharmaceutical Tech Shanghai Co Ltd | Compuesto de oxido de fenilarsina halogenado y aplicacion del mismo. |
| CN116478954B (zh) * | 2023-02-14 | 2025-06-10 | 中国农业大学 | 水稻基因OsPI4K及其在水稻抗稻瘟病中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002365110A1 (en) * | 2001-07-10 | 2003-07-15 | Massachusetts Institute Of Technology | Small molecule microarrays |
| EP2319926B1 (en) * | 2007-07-05 | 2016-08-31 | Arrowhead Research Corporation | DSRNA for treating viral infection |
| WO2016172952A1 (zh) * | 2015-04-30 | 2016-11-03 | 江苏挪贝肽医药科技有限公司 | PI4KIIIα蛋白及相关的膜蛋白复合体在治疗阿尔茨海默病中的应用 |
| WO2019200043A1 (en) * | 2018-04-11 | 2019-10-17 | New Mexico Tech University Research Park Coporation | Lipid prodrugs for use in drug delivery |
| EP4130014A4 (en) * | 2020-03-31 | 2024-05-15 | Nuo-Beta Pharmaceutical Technology (Shanghai) Co., Ltd. | Deuterated oxophenylarsine compound and use thereof |
| MX2024004055A (es) * | 2021-09-30 | 2024-06-19 | Nuo Beta Pharmaceutical Tech Shanghai Co Ltd | Compuesto de oxido de fenilarsina halogenado y aplicacion del mismo. |
-
2020
- 2020-07-03 TW TW109122503A patent/TW202126294A/zh unknown
- 2020-07-06 EP EP20836327.5A patent/EP3995134A4/en active Pending
- 2020-07-06 CN CN202080049288.5A patent/CN114555056B/zh active Active
- 2020-07-06 WO PCT/CN2020/100377 patent/WO2021004422A1/zh not_active Ceased
- 2020-07-06 JP JP2022526849A patent/JP2022538505A/ja active Pending
- 2020-07-06 AU AU2020309681A patent/AU2020309681A1/en not_active Abandoned
- 2020-07-06 CN CN202311755839.1A patent/CN118105372A/zh active Pending
- 2020-07-06 CA CA3149104A patent/CA3149104A1/en active Pending
- 2020-07-06 PE PE2022000005A patent/PE20220942A1/es unknown
- 2020-07-06 US US17/624,850 patent/US20230115711A1/en not_active Abandoned
- 2020-07-06 MX MX2022000287A patent/MX2022000287A/es unknown
- 2020-07-06 BR BR112022000155A patent/BR112022000155A2/pt not_active Application Discontinuation
- 2020-07-06 KR KR1020227003749A patent/KR20220071175A/ko not_active Ceased
- 2020-07-06 PH PH1/2022/550254A patent/PH12022550254A1/en unknown
-
2022
- 2022-01-03 IL IL289586A patent/IL289586A/en unknown
- 2022-02-07 CO CONC2022/0001218A patent/CO2022001218A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20220071175A (ko) | 2022-05-31 |
| CN118105372A (zh) | 2024-05-31 |
| EP3995134A4 (en) | 2023-07-12 |
| WO2021004422A1 (zh) | 2021-01-14 |
| JP2022538505A (ja) | 2022-09-02 |
| EP3995134A1 (en) | 2022-05-11 |
| CA3149104A1 (en) | 2021-01-14 |
| CN114555056B (zh) | 2024-01-05 |
| TW202126294A (zh) | 2021-07-16 |
| AU2020309681A1 (en) | 2022-02-24 |
| BR112022000155A2 (pt) | 2022-04-12 |
| PE20220942A1 (es) | 2022-05-31 |
| US20230115711A1 (en) | 2023-04-13 |
| CO2022001218A2 (es) | 2022-05-20 |
| PH12022550254A1 (en) | 2023-06-26 |
| MX2022000287A (es) | 2022-06-16 |
| CN114555056A (zh) | 2022-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL285302A (en) | Compounds, preparations and methods | |
| PL3915989T3 (pl) | Inhibitor jak i sposób jego otrzymywania | |
| GB201904104D0 (en) | Composition, method and use | |
| IL278036A (en) | 1HPK inhibitors, method of preparation and administration | |
| IL285595A (en) | Spt5 inhibitors and uses thereof | |
| IL279637A (en) | Cell necrosis inhibitor, preparation method therefor and use thereof | |
| IL278758A (en) | VMAT2 inhibitory compounds, compositions and methods related thereto | |
| SG11202106998TA (en) | Strains, composition and method of use | |
| GB201901099D0 (en) | Methods, uses and compositions | |
| GB202017595D0 (en) | Compositions, and methods and uses relating thereto | |
| GB201911367D0 (en) | Composition, paste and methods | |
| IL325537A (en) | Iraq inhibitor and its preparation and use | |
| IL289416A (en) | Tricyclic compound, its preparation method and use | |
| RS67832B1 (sr) | Kompozicija i kontejner, komplet, postupak upotrebe | |
| GB2587074B (en) | Composition, paste and methods | |
| PL4011494T3 (pl) | Chip mikro- i nano-przepływowy, sposób jego wytwarzania oraz jego zastosowania | |
| IL287120A (en) | Compounds, preparations and methods | |
| EP3995134A4 (en) | MICROMOLECULAR PI4KIIIALPHA INHIBITOR COMPOSITION, METHOD FOR PREPARATION AND USE | |
| EP3831828A4 (en) | BRD4 INHIBITOR, METHOD OF PREPARATION AND USE THEREOF | |
| GB202013911D0 (en) | Composition, paste and methods | |
| ZA202104192B (en) | Mmpl3 inhibitors, compositions and uses thereof | |
| EP4043436A4 (en) | MAGL INHIBITOR, ITS MANUFACTURING PROCESS AND ITS USE | |
| GB2579687B (en) | Composition and method | |
| GB202107977D0 (en) | Method, composition and use | |
| GB201914777D0 (en) | Composition and method |